相关实验视频

Updated: Jan 13, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

维巴斯科西德通过向抗衰老信号来抑制表皮细胞-半机细胞过渡和线粒体生物发生,这种信号在割耐药的前列腺癌中被发现

Hsing-Chia Mai^1,2,3, Pei-Fang Hsieh^4,5, Chun-Hsien Wu^1,3,4,6

¹Department of Urology, E-Da Cancer Hospital, Kaohsiung, Taiwan, R.O.C.

Cancer genomics & proteomics

|October 28, 2025

概括

一种天然化合物Verbascoside通过减少细胞迁移,氧化应激和衰老来对抗侵袭性前列腺癌. 它增强了线粒体的功能,并抑制了驱动癌症进展的关键途径.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

抗割前列腺癌 (CRPC) 是一种具有攻击性的恶性瘤.
维巴斯科赛德是一种类乙基化物,对CRPC的治疗有前途.
维巴斯科赛德的作用背后的机制需要阐明.

研究的目的:

在CRPC中研究Verbascoside的抗和抗转移效应.
阐明维巴斯科赛德对表皮细胞 - 介质细胞过渡 (EMT),氧化应激和线粒体生物发生的影响.
分析Verbascoside对老化相关分泌表型 (SASP) 和细胞周期调节者的调节.

主要方法:

用Verbascoside处理的CRPC细胞模型.
西方涂抹和ELISA用于评估EMT标记物,氧化应激,线粒体调节剂和细胞因子.
对p38 MAPK,p16,p21,p27和Rb进行衰老和增殖的分析.

主要成果:

维巴斯科赛德抑制了EMT,降低了氧化应激,并增强了线粒体生物发生.
抑制了促炎性细胞因子 (IL-6,IL-8,IL-1) 的分泌.
降低p38 MAPK激活和下调p16,p21,p27和Rb,减少衰老和增殖.

结论:

维巴斯科西德通过调节EMT,氧化应激,线粒体功能和衰老通路来减弱CRPC进展.
突出了维巴斯科赛德在攻击性前列腺癌中向衰老的潜力.
为未来针对衰老的CRPC管理策略提供基础.

关键词:

这是一种Verbascoside.这是一种抗衰老的药物.割抗性前列腺癌是什么?表皮介质介质的过渡.线粒体生物发生是线粒体生物发生.

更多相关视频

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...